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Transcriptomic analysis of equine
chorioallantois reveals immune networks
and molecular mechanisms involved
in nocardioform placentitis
Hossam El‑Sheikh Ali1,2, Shavahn C. Loux1, Laura Kennedy3, Kirsten E. Scoggin1, Pouya Dini1,
Carleigh E. Fedorka1, Theodore S. Kalbfleisch1, Alejandro Esteller‑Vico4, David W. Horohov1, Erdal Erol3,
Craig N. Carter3, Jackie L. Smith3 and Barry A. Ball1*

Abstract
Nocardioform placentitis (NP) continues to result in episodic outbreaks of abortion and preterm birth in mares and
remains a poorly understood disease. The objective of this study was to characterize the transcriptome of the cho‑
rioallantois (CA) of mares with NP. The CA were collected from mares with confirmed NP based upon histopathology,
microbiological culture and PCR for Amycolatopsis spp. Samples were collected from the margin of the NP lesion
(NPL, n = 4) and grossly normal region (NPN, n = 4). Additionally, CA samples were collected from normal postpartum
mares (Control; CRL, n = 4). Transcriptome analysis identified 2892 differentially expressed genes (DEGs) in NPL vs. CRL
and 2450 DEGs in NPL vs. NPN. Functional genomics analysis elucidated that inflammatory signaling, toll-like receptor
signaling, inflammasome activation, chemotaxis, and apoptosis pathways are involved in NP. The increased leukocytic
infiltration in NPL was associated with the upregulation of matrix metalloproteinase (MMP1, MMP3, and MMP8) and
apoptosis-related genes, such as caspases (CASP3 and CASP7), which could explain placental separation associated
with NP. Also, NP was associated with downregulation of several placenta-regulatory genes (ABCG2, GCM1, EPAS1, and
NR3C1), angiogenesis-related genes (VEGFA, FLT1, KDR, and ANGPT2), and glucose transporter coding genes (GLUT1,
GLUT10, and GLUT12), as well as upregulation of hypoxia-related genes (HIF1A and EGLN3), which could elucidate
placental insufficiency accompanying NP. In conclusion, our findings revealed for the first time, the key regulators
and mechanisms underlying placental inflammation, separation, and insufficiency during NP, which might lead to the
development of efficacious therapies or diagnostic aids by targeting the key molecular pathways.
Keywords: Equine, Nocardioform placentitis, Chorioallantois, Transcriptome, Amycolatopsis spp.
Introduction
Nocardioform placentitis (NP) is defined as a focal
mucoid placental inflammation in which the bacterial
infection is limited to the chorionic surface of the ventral
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placenta without infection of the fetus [1, 2]. NP was
first diagnosed in central Kentucky (KY) in 1986 [3] with
subsequent epizootics occurring there in 1998, 1999,
2011, 2017, and 2020 [1, 4]. Cases of NP have also been
reported sporadically in Florida [5], South Africa [6], Italy
[7] and most recently in New Zealand [8]. NP is characterized by late-term abortions, premature foals, neonatal
deaths, and weak foals at term associated with an apparent fetal growth retardation due to placental separation
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and insufficiency with large areas of the chorion that may
be involved with the lesion [1]. NP lesions may also be
seen in the CA in mares with normal neonates. The distribution of the placental lesion in NP is distinct from
those of ascending bacterial placentitis with lesions of
NP mainly distributed in the cranial-ventral portion of
the placenta near the junction of the uterine horns and
body [1]. The lesion is often sharply demarcated from the
surrounding normal placenta, and the affected placenta
is covered with a thick, tan mucoid material [1, 2]. Histologically, the chorioallantois may demonstrate infiltration of neutrophils, lymphocytes, and macrophages with
hyperplasia of the chorionic epithelium [1]. The surface
exudate contains sloughed epithelial cells, leukocytes and
an eosinophilic, amorphous material. Centrally, the chorionic villi are blunted and atrophied with lymphocytic
infiltrates [1].
Nocardioform placentitis is associated with gram-positive, branching actinomycetes including Amycolatopsis
spp., and Crossiella equi along with more recently characterized isolates of Streptomyces atriruber and Streptomyces silaceus, among others [9]. Characterization of
actinomycetes associated with abortions during the 2011
outbreak of NP in central Kentucky revealed that Amycolatopsis spp. (49% of cases) was the most common, with
Crossiella equi (29% of cases) as the next most frequent
isolate [10].
To date, the pathogenesis of the disease remains poorly
understood. Attempts to induce the infection in mares by
intrauterine inoculation of Crossiella equi at the time of
breeding or in pregnant mares via oral, intravenous, and
intranasal routes with Crossiella equi were unsuccessful
[11]. Like pathogenesis, the ecology and biology of the
causative organisms, Crossiella equi and Amycolatopsis spp. remain unknown, as these organisms have only
been isolated from affected placentae in mares. Additionally, the pathophysiology of the NP and the key regulators
underlying placental inflammation, separation and insufficiency during NP remains unclear. These gaps in our
knowledge about the disease are limiting the advancement toward efficient diagnostic, prevention and treatment protocols for NP.
The application of high-dimensional biology, such as
RNA-sequencing could aid in revealing the NP transcriptomic signature, identifying the immune networks
and pathways involved in NP with consequent elucidation of the pathophysiology of the disease. The better
understanding of these key regulators and mechanisms
holds potential for the development of new diagnostic
tools and therapies to forestall NP-induced preterm
labor. Therefore, the current study aimed to compare
the transcriptomic changes in the CA of mares with
NP with tissues collected from unaffected regions of
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chorioallantois as well as gestationally age-matched
control CA.

Materials and methods
Experimental design

During the 2017 foaling season, thoroughbred mares in
central KY with suspected nocardioform placentitis had
placental tissues collected at the time of foaling or abortion for subsequent histopathologic evaluation as well as
RNA isolation. Within three hours of foaling/abortion,
two samples were taken from the CA at the margin of the
NP lesion (NPL, Figure 1A) using an 8-mm biopsy punch.
One sample was fixed in 10% formalin, and one sample
was preserved in RN = Alater® (#AM7021; Invitrogen).
In addition, two samples were also taken from a normalappearing region of the CA (NP normal; NPN, Figure 1A)
over the uterine body and preserved as mentioned above.
Tissues were handled carefully to avoid contamination
with soil, manure, bedding or other foreign material. The
remaining CA was submitted to the University of Kentucky Veterinary Diagnostic Laboratory for complete
gross and histopathologic evaluation, as well as microbiology and PCR for Amycolatopsis spp. and Crossiella equi
[10]. Among the collected cases, four cases (NPL = 4 and
NPN = 4) were confirmed as Nocardioform placentitis
(Amycolatopsis spp.) based upon microscopic examination of the placenta (presence of gram-positive branching bacilli) and confirmation by PCR [10]. Additionally,
normal postpartum placenta (Control; CRL, n = 4) were
collected from four normal foaling mares, and these placentae were also examined at the UKVDL to confirm
normal placenta based upon pathological and microbiological examination.
Total RNA extraction

Total RNA was isolated from all CA samples using the
RNeasy Mini Kit (#74,104; Qiagen), and DNA digestion
was performed on-column using RNase-free DNase I
(#79,254: Qiagen), followed by cleanup procedures. All
procedures were performed according to the manufacturer’s instructions. After extraction, RNA concentration
and quality were analyzed using a Nanodrop 2000 spectrophotometer (#ND-2000; Thermo Fisher Scientific)
and the Bioanalyzer® (Agilent, Santa Clara, CA, USA).
All samples had a 260/280 ratio > 2.0 and RNA integrity
number (RIN) > 9.0.
Next‑generation RNA sequencing (RNA‑seq)

Next-generation RNA-seq was performed at the University of Louisville Center for Genetics and Molecular Medicine as described elsewhere [12]. In brief, the
mRNA libraries were prepared from total RNA using
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Figure 1 Sampling sites from the nocardioform placentitis group and the histopathological evaluation of inflammation score. A In
the nocardioform placentitis group we collected chorioallantois samples from two sites. The fist sampling site (NPL) was at the margin of the
nocardioform placentitis lesion. The second sampling site (NPN) was chosen where the chorionic surface is red and velvet in appearance with no
gross evidence of pathology. B, C The inflammation score in the different sets (CRL, NPN, and NPL) and reprehensive H&E images of the different
inflammation scores. The inflammation was graded as score zero (no inflammation; no inflammatory cells), score 1 (mild inflammation; few
leukocyte infiltration), score 2 (moderate inflammation; moderate leukocyte infiltration), and score 3 (marked inflammation; large numbers of
inflammatory cells).
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TruSeq® Stranded mRNA Library Prep (#20,020,594;
Illumina). Libraries were diluted to 10 nM, pooled, further diluted and denatured to single strand and run on
a NextSeq 500 v2 (Illumina, San Diego, CA, USA) 300
cycle, High Output kit in a 2 × 150 bp PE read.
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Reads were trimmed for quality and adapters with TrimGalore 0.4.3, then mapped to EquCab3.0 using STAR
2.5.3a [13]. Expression values (Fragments Per Kilobase
of transcript per Million fragments mapped; FPKM) of
mapped reads were quantified using Cufflinks 2.2.1 [14]
with the ENSEMBL annotation (ENSEMBL v.88). Differentially expressed genes (DEGs) were evaluated using
Cuffdiff 2.2.1 based upon a false discovery rate (FDR)
adjusted p-value < 0.05 after Benjamini–Hochberg correction for multiple-testing [14]. The DEGs were represented as heatmaps using the R-package “gplots” [15].
The overlap between DEGs in the NPL vs. CRL, NPL vs.
NPN and NPN vs. CRL was illustrated with Venn diagrams using BioVenn and UpSet. The current RNA-seq
data was deposited in the Gene Expression Omnibus
(GEO; GSE154637) repository. The bioinformatics and
functional genomics pipeline is summarized and illustrated in Additional file 1.

algorithm was used to identify gene modules or clusters
(i.e., genes with high topological overlap). Gene clusters
were visualized by the heatmap plot (TOM plot) of the
gene network topological overlap. Module relationships
were summarized by a hierarchical clustering dendrogram and TOM plot of module eigengenes (MEs). The
associations between the gene clusters and the score of
the trait of interest (i.e., inflammation score for each sample) were tested by correlating MEs to trait score. GO
analysis (biological process) was performed on gene lists
derived from module of interest. Module memberships
(MM, i.e., the correlation between each gene’s expression
profile with the ME of a given module as an indicator
of the intramodular connectivity) and gene significance
(GS, i.e., the correlation between the gene expression
profile (FPKM) and the trait score (inflammation score)
as a measure of biological relevance) were calculated
[18]. The genes (network nodes) having MM ≥ 0.90,
p-value < 0.05 and GS ≥ 0.6 were identified as intramodular hub genes [19].
To further investigate the cross-talk between DEGs
in NP, we matched our DEGs with the available ligand–
receptor pairs in the FANTOM5 database for protein-coding genes [20]. This dataset includes 2557
ligand-receptor interactions.

Functional genomics

Validation of RNA‑seq using quantitative RT‑PCR

To investigate the biological functions of DEGs, DAVID
Bioinformatics Resources version 6.8 along with the
PANTHER pathways version 13.0 were used to functionally annotate genes based on gene ontology (biological
process and pathways).
To predict upstream regulators relevant for each set of
DEGs, upstream regulator analysis was carried out using
Ingenuity pathway analysis (IPA, 2018) as described
elsewhere [12]. To investigate the interaction and relationships between the potential upstream regulators, all
known protein–protein interactions were referenced and
matched using String version 10.5. The resultant interaction networks were visualized using Cytoscape version
2.8.3.
Weighted gene co-expression network analysis was carried out using WGCNA version 1.66 package in R [16] to
construct gene co-expression networks as described elsewhere [17]. Gene co-expression clusters were generated
from the all DEGs in NPL as described elsewhere [12]. In
brief, following the construction of a matrix of pairwise
correlations between all pairs of genes across the samples
(n = 12), a weighted adjacency matrix was generated by
raising co-expression similarity to a power β = 9 as determined for these sample sets. Then, a topological overlap
matrix (TOM) was assembled and used as input for hierarchical clustering analysis. Then, a dynamic tree-cutting

For gene expression analysis, total RNA was reverse
transcribed using TaqMan™ Reverse Transcription Reagents (#4,368,814; Invitrogen™). RT-qPCR was performed using PowerUp™ SYBR™ Green Master Mix
(#A25741; Applied Biosystems™) along with specific
primers designed for a subset of six selected targets
using Primer-BLAST (NCBI) as described in Table 1,
with actin beta (ACTB) and glucuronidase beta (GUSB)
as reference genes based on Normfinder software (version 0.953) as described elsewhere [21]. PCR efficiency
was evaluated using LinRegPCR (version 11.0) to ensure
that all evaluated transcripts resulted in a PCR efficiency
between 1.8 and 2.2 [22]. Delta CT (ΔCT) values calculated where ΔCT = (CT values of mRNA of interest—CT
value of the reference genes). Results are presented as
-ΔCT. One-way ANOVA was used to evaluate the significance of any changes in mRNA expression of tested
targets between CRL, NPN and NPL groups, followed by
a pairwise comparison of means using unpaired T-test.
Differences of P < 0.05 were considered as statistically
significant and any difference of 0.1 > P ≥ 0.05 was considered a trend. Pearson’s correlation was used to examine
the correlation between mRNA expression results from
RT-qPCR (−ΔCT) and the RNA-sequencing (normalized
FPKM: Log2[FPKM + 1]) for each transcript. Descriptive

Bioinformatics pipeline
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Table 1 Forward and reverse primer sequences used for RT-qPCR analysis
Gene

Forward

Reverse

Accession

Amplicon
size (bp)

IL1β

CAGTCTTCAGTGC TCAGGT TTC TG

CATTGCCGCTGCAGTAAGT

XM_001495926.4

84

IL1RN

GCCTGTGTCAAGTCTGGTGA

ACTC TTTGGGCTTGTTGGTG

XM_005599766.3

217

IL6

GGATGCT TCCAATCTGGGT TCAAT

TCCGAAAGACCAGTGATGATTTT

NM_001082496.2

65

PLAC8

GTTTCATGTGCCT TGCGTTGT

ATATCGGGTCCGGTAGAGGG

XM_003364673.4

98
169

SAA1

CCTGGGC TGC TAAAGTCATC

AGGCCATGAGGTC TGAAGTG

XM_023646155.1

INHBA

CCTCCTC TTCCTTCTTCTTCTTCTT

GCAAGAGCTCCCTGGATAT T

XM_023638729.1

GUSB

GGGATTCGCACTGTGGCTGTCA

CCAGTCAAAGCCC TTCCCTCGGA

XM_001493514

117

ACTB

CGACATCCGTAAGGACCTGT

CAGGGCTGTGATC TCC TTC T

NM_001081838

100

99

Primers were generated using Primer-BLAST (NCBI).
Key: RT-qPCR, Real time quantitative polymerase chain reaction; NCBI, National Center for Biotechnology Information; IL1β, Interleukin 1β; IL1RN, Interleukin 1
Receptor Antagonist; IL6, Interleukin 6; PLAC8, Placenta-specific 8; SAA1, Serum Amyloid A1; INHBA, Inhibin Subunit Beta A; ACTB, actin beta; GUSB, Glucuronidase
Beta.

statistics are expressed below as the mean ± standard
error of the mean (SEM).

Buffalo Grove, IL, USA) as described elsewhere [23].
Slides were evaluated at 100 and 200× magnification.

Tissue preparation for histopathological examination
and immunohistochemical staining

Statistical analysis

The fixed full-thickness CA samples were dehydrated,
embedded in paraffin using routine methods, and sectioned at 5 μM. For histopathological examination,
sections were stained with hematoxylin and eosin.
The inflammation score was determined based on the
amount of inflammation in the placenta and was graded
as zero (no inflammation; no inflammatory cells), 1
(mild inflammation; few leukocyte infiltration), 2 (moderate inflammation; moderate leukocyte infiltration)
and 3 (severe inflammation; large numbers of inflammatory cells). Average scores for placenta were calculated for each sample based on random evaluation of
three different high-power fields. The inflammation
score and representative H&E images of the different
scores are shown in Figures 1B and C.
For IHC, immunostaining of sectioned tissues was
conducted using mouse anti-human calgranulin B
(S100A9 1:1000, #MA1-81381 ThermoFisher Scientific), mouse anti-human caspase 7 (CASP7 1:200, #SC28295, Santa Cruz Biotechnology), mouse anti-human
hypoxia inducible Factor 1 subunit alpha (HIF1A
1:200,#MA1-16504, ThermoFisher Scientific), mouse
anti-human vascular endothelial growth factor (VEGF
1:50, # MA5-13182, ThermoFisher Scientific), rabbit
anti human T-Box Transcription Factor 21 (TBX21
1:400, #PA5-28881, ThermoFisher Scientific), and rabbit anti-human cytochrome P450 family 11 subfamily
A member 1 (CYP11A1 1:1000, # NBP1-85368, Novus
Biologicals). Paraffin sections were processed with
the Leica BOND-MAX system (Leica Microsystems,

An unpaired T-test was used to evaluate the significance of any changes in gestational age and foal birthweight between control and NP groups. One-way
analysis of variance (one-way ANOVA) was used to
evaluate the significance of any changes in inflammation score between CRL, NPN, and NPL, followed by
a pairwise comparison of means using Tukey’s honestly
significant difference (HSD) post hoc test. Differences
of P < 0.05 were considered as statistically significant
and any difference of 0.1 > P ≥ 0.05 was considered
a trend. Descriptive statistics are expressed as the
mean ± standard error of the mean (SEM).

Results
Clinical and technical data

The four confirmed nocardioform placentitis (Amycolatopsis spp.) cases and four control mares delivered live
foals at term (Table 2). The birthweights of foals born
to mares with NP were lower (P = 0.025). Gestational
lengths did not show significant difference (P = 0.14)
between mares with NP and controls (Table 2). Further
details about mares clinical and histopathological findings are presented in Additional file 2. The integrity of
RNA recovered from both NP and control tissues was
very high (RIN > 9; Table 3).
Transcriptomic profiling and coverage

In total, 94.44 million reads were generated from all
cDNA libraries, with an average of 7.87 million reads
per sample. An average of 86.9% (range 85.7–88.2%)
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Table 2 Summary of mare data for tissue collections from nocardioform placentitis and control mares
Category

Number

Mare age
(years)

Gestational age
(days)

Foal outcome

Nocardioform
placentitis

4

11.3 ± 2.4

337 ± 9.3

4 live foals

114 ± 12.3a

106 ± 48

Control

4

9.3 ± 0.8

348 ± 6.6

4 live foals

138.8 ± 11.4b

38 ± 13

Different superscripts (a and b) indicate significant difference within the same column.

Table 3 RNA integrity of chorioallantois collected from NP
and control mares
Category
Nocardioform lesion
Nocardioform normal
Control

RNA integrity
number (RIN)
9.5 ± 0.3

9.7 ± 0.3

9.75 ± 0.26

of reads was mapped to the equine reference genome
(EquCab3.0). FPKM distribution and principal component analysis (PCA) of the equine CA transcriptome
from mares in CRL, NPN, and NPL is depicted in Figures 2A and B. Further details about individual sample
read count, and mapping quality are presented in Additional file 3.
Differential gene expression

The differentially expressed genes (DEGs) in NPL vs.
CRL, NPN vs. CRL and NPL vs. NPN and the overlap
between these DEGs are represented in Figures 2C–F
and Additional file 4. CA from NPL exhibited differential expression (FDR < 0.05) of 2892 genes (1898 upregulated and 994 downregulated) relative to CRL. Moreover,
CA from NPL exhibited differential expression of 2450
genes (1580 upregulated and 870 downregulated) relative
to NPN. A total of 2189 DEGs were shared in common
between NPL vs. CRL and NPL vs. NPN (Figure 2D).
Gene expression of the CA from CRL and NPN clustered

Foal birthweight
(pounds)

Interval from foaling
to tissue collection
(minutes)

together suggesting relatively fewer differences in gene
expression (i.e., 89 DEGs) between the two sample sets.
This might suggest that NP have a lesser impact on the
chorioallantois beyond the lesion zone.
Gene ontology (GO) enrichment and pathway analysis

Functional annotation of DEGs in NPL demonstrated
that these genes were mainly involved in biological processes associated with inflammatory response, immune
response, immunoglobulin mediated immune response,
cellular response to lipopolysaccharide, toll-like receptor signaling pathway, B cell receptor signaling pathway,
defense response to virus, angiogenesis, and chemotaxis, among others (Figures 3A and B). Moreover, pathway analysis of DEGs in NPL revealed that these genes
are involved in relevant pathways such as inflammatory
signaling (interleukin signaling, inflammation mediated
by chemokine and cytokine signaling pathway, toll-like
receptor signaling, B cell activation, and T cell activation), angiogenesis-related pathways (VEGF signaling,
angiogenesis, endothelin signaling pathway and PDGF
signaling pathway), cytostructural integrity (integrin
signaling pathway), and apoptosis signaling pathway,
among others (Figures 4A and B).
Upstream regulators and their targets

The upstream regulator analysis identified 73 activated
upstream regulators (P-value of overlap is < 0.05 and
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Figure 2 Transcriptomic Analysis of the Chorioallantois (CA) from Mares with Nocardioform Placentitis. A Violin plot showing transcripts’
FPKM distribution in CA in control (CRL), nocardioform placentitis lesion (NPL), and nocardioform placentitis normal region (NPN) sets. The plots
display the distribution of the data using kernel density plots (outer shapes). The inner horizontal lines show the interquartile range (the two
outer thin lines), the median (the central thick line). B Principal component analysis (PCA) of the equine CA transcriptome from mares in CRL, NPN,
and NPL sets. C Heat map of differentially expressed genes (DEGs; FDR < 0.05) in NPL vs. CRL, NPL vs. NPN, and NPN vs. CRL sets. The heat map
was created using the normalized FPKMs of the DEGs (log10 [FPKM of the DEG + 1]). Normalized expression values are indicated on a color scale
with red indicating high expression (positive z-score) and green indicating low expression (negative z-score). The circles at the bottom indicate
the sample group (green = CRL, yellow = NPN, and red = NPL). The heat map was generated using the R package “heatmap.2”. D Venn diagram
representing DEGs in common between NPL vs. CRL, NPL vs. NPN, and NPN vs. CRL sets. E UpSet diagram illustrating the intersection between
DEGs (upregulated and downregulated) in NPL vs. CRL, NPL vs. NPN, and NPN vs. CRL sets. The nature of each intersection is indicated by the dots
below the vertical bar plot. The vertical bars show the number of DEGs in each intersection, while the horizontal bars show the number of DEGs in
each comparison. Key; CRL; normal postpartum (control), NPL; nocardioform placentitis lesion, and NPN; nocardioform placentitis normal region.
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Figure 3 Overrepresented biological process in equine chorioallantois (CA) in NPL vs. CRL and NPL vs. NPN sets. Gene ontology (GO)
enrichment analysis was used to identify the overrepresented biological process from the DEGs in NPL vs. CRL set (A) and NPL vs. NPN set (B).
The biological processes are visualized by GOplot package in R “GOCircle “. The inner circle is a bar chart where the height of the bar denotes the
significance of the GO term (− log10 adjusted P-value), and color links to the z-score. The outer circle displays dot plots of the logFC for the genes in
each term. Key; CRL; normal postpartum (control), NPL; nocardioform placentitis lesion, and NPN; nocardioform placentitis normal region.
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Figure 4 Overrepresented PANTHER pathways in equine chorioallantois (CA) in NPL vs. CRL and NPL vs. NPN sets. PANTHER pathway
analysis was used to identify the overrepresented pathways from the DEGs in in NPL vs. CRL set (A) and NPL vs. NPN set (B). The bars represent the
number of genes in each overrepresented pathway, and the dotted line represents –Log10 (Adj P-value). Key; CRL; normal postpartum (control),
NPL; nocardioform placentitis lesion, NPN; nocardioform placentitis normal region, PANTHER; Protein ANalysis THrough Evolutionary Relationships.
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Figure 5 Potential upstream regulators in equine chorioallantois (CA) during nocardioform placentitis (NP) as identified by upstream
regulator analysis performed on Ingenuity Pathway Analysis (IPA). A Venn diagram representing potential upstream regulators in common
between NPL vs. CRL and NPL vs. NPN sets. B Protein–protein interactions network between upstream regulators identified NPL vs. CRL and NPL
vs. NPN sets. Protein–protein interactions network was generated by STRING version 10.3. and visualized with Cytoscape 2.8.6. Red circles indicate
activated upstream regulator, while green circle indicate inhibited upstream regulator. Key; CRL; normal postpartum (control), NPL; nocardioform
placentitis lesion, and NPN; nocardioform placentitis normal region.
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Figure 6 Weighted gene expression co-expression network analysis (WGCNA) of DEGs in equine chorioallantois (CA) during
nocardioform placentitis dataset. A Gene module (clusters) identification as determined by WGCNA. B Matrix with the module-trait relationships
and corresponding p-values of the modules on the y-axis and selected traits related with treatment on the x-axis. The y-axis is colored according
to the correlation, with red representing a strong positive correlation and green representing a strong negative correlation. C Number of genes
per module. D, E Module-trait correlation heatmap based on correlation analysis of module eigengenes (MEs) and inflammation score in placenta
(n = 12). The turquoise, yellow, and brown modules presented a significant positive correlation with inflammation score (p-values < 0.05). F
Over-represented biological process in the turquoise module. G A scatter plot of GS for inflammation score versus the MM in the turquoise module.
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Figure 7 Ligand-receptors interaction analysis of DEGs during nocardioform placentitis. Genes shown in red are significantly upregulated
in the chorioallantois (CA) from the nocardioform placentitis lesion (NPL) in comparison to normal postpartum (CRL). Genes shown in green are
significantly downregulated in NPL in comparison to CRL. Genes shown in black are those that did not show any significant change in NPL in
comparison to CRL.

Z-score ≥ 2) among the DEGs in both NPL vs. CRL and
NPL vs. NPN (Figure 5A). Those activated upstream regulators included 55 regulators in common between both sets.
Those 55 regulators include genes coding for transcription
factors (ETS1, IRF1, IRF7, MYBL2, NFAT5, NFKB2, PML,
REL, RELB, SPL1, STAT1, STAT2 and STAT4), transmembrane receptors (CD2, CD40, ICAM1, SELP, TLR2, TLR3,
TLR5, and TLR7), and cytokines (CCL5, CD40LG, FLT3LG,
IL1A, IL1B, IL7, IL18, TNFSF10, TNFSF13B), among others. Also, this analysis identified nine inhibited upstream
regulators (P-value of overlap is < 0.05 and Z-score ≤ -2)
among the DEGs in both NPL vs. CRL and NPL vs. NPN.
Those inhibited upstream regulators included seven regulators (A2M, AGA
, B4GALNT1, CBX7, CREM, DAG1,
and NR3C1) in common between both sets. The identified
upstream regulators and their target molecules in NPL vs.
CRL and NPL vs. NPN are represented in Additional files
5A and B, respectively. The overlap between identified
potential upstream regulators in NPL vs. CRL and NPL vs.
NPN is depicted in Figure 5A. Moreover, the interaction
between identified potential upstream regulators is illustrated in Figure 5B.
Weighted co‑expression network analysis (WGCNA)

WGCNA was carried out to gain further insights on the
DEGs co-expression patterns and to identify the genes
with the highest interaction or connectivity (hub genes)

among those DEGs in NPL vs. CRL and NPL vs. NPN.
Co-expression analysis of the DEGs in NPL identified
five gene modules (clusters) as presented in Figure 6 and
Additional file 6. Among these modules, turquoise, yellow and brown modules were positively associated with
inflammation score. But the blue module was negatively
correlated to this trait. It is worth noting that, the turquoise module showed the highest adjacency to inflammation score trait as presented in Figure 6E.
Ligand‑receptor interaction analysis

To gain further insights on the interaction between DEGs,
ligand-receptor interaction analysis identified 1038 possible
interactions in NP. These interactions elucidate the impact
of NP on placental autocrine and paracrine signaling in
comparison to normal parturition. A representative set of
Ligand-receptor interactions is presented in Figure 7 and the
complete list of interactions is provided in Additional file 7.
RT‑qPCR validation

RT-qPCR confirmed the differential expression of six
genes in NPL in comparison to CRL and/or NPN group
as illustrated in Figure 8. Analysis of the correlation
between gene expression results from RT-qPCR (−ΔCT)
and the RNA-sequencing (normalized FPKM) showed
that all genes had a significant correlation between the
two methods (Figure 8).
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Figure 8 RT-qPCR validation of six selected differentially expressed genes from RNA-sequencing results. Expression of each mRNA was
determined by qRT-PCR, normalized to ACTB and GUSB, expressed as −∆CT. Data are presented as a dot plot, and the middle horizontal line
represents the mean while error bars represent the standard error of the mean (SEM). Asterisks indicate the presence of a significant difference
between groups (*P < 0.05; **P < 0.01, *** P < 0.001). Dagger (†) indicates the presence of a trend (0.1 > P ≥ 0.05). Pearson’s correlation coefficient (r)
between mRNA expression results from RT-qPCR (−ΔCT) and the RNA-sequencing (FPKM) is represented for each transcript. Key; IL1β, Interleukin
1β; IL1RN, Interleukin 1 Receptor Antagonist; IL6, Interleukin 6; PLAC8, Placenta-specific 8; SAA1, Serum Amyloid A1; INHBA, Inhibin Subunit Beta A;
ACTB, actin beta; GUSB, Glucuronidase Beta.

Immunohistochemistry

The protein localization and staining intensity for CASP7,
TBX21, VEGF, S100A9, CYP11A1, HIF1A, and SAA1
in equine CA retrieved from CRL, NPN, and NPL sets
are shown in Figure 9. Based upon immunolocalization,

CASP7 was predominantly expressed in the nucleus and
cytoplasm of chorionic epithelium in NPL compared
to CRL and NPN. S100A9 and TBX21 appeared to be
mainly expressed in immune cells in CA retrieved from
CRL, NPN, and NPL with a higher number of S100A9
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Figure 9 Representative photomicrographs of the equine placenta retrieved from CRL, NPN, NPL, and immunostained for S100A9,
CASP7, HIF1A, VEGF, TBX21, and CYP11A1. Bar = 100 µm. Key; CRL; normal postpartum (control), NPL; nocardioform placentitis lesion, and NPN;
nocardioform placentitis normal region, CASP7; caspase 7, HIF1A; hypoxia inducible Factor 1 subunit alpha, VEGF; vascular endothelial growth factor,
CYP11A1; cytochrome P450 family 11 subfamily A member 1.
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and TBX21 positive cells in NPL. The expression of both
VEGF and CYP11A1 was predominant in the cytoplasm
of the chorionic epithelium. VEGF showed a higher
immunolabeling intensity in CA retrieved from CRL and
NPN compared to NPL. In contrast, CYP11A1 showed
a higher immunolabeling intensity in CA retrieved
from NPL compared to CRL and NPN. HIF1A was
mainly expressed in the nucleus of chorionic epithelium,
endothelial cells and vascular smooth muscle cells in
blood vessels as well as scattered stromal cells within the
CA with a higher number of HIF1A positive cells in NPL
set. It is worth noting that inflammatory cells did not display any positive immunolabeling for HIF1A. Overall, the
immunostaining intensity for all evaluated targets was
consistent with the transcript expression in the current
RNA-Seq dataset.

Discussion
To the authors’ knowledge, this is the first study to assess
transcriptomic changes in the CA of mares with spontaneous NP (Amycolatopsis spp.). The current study presents a distinct transcriptome signature of equine NP
(Amycolatopsis spp.) and adds to the understanding of
the key regulators and molecular mechanisms involved in
the disease. Overall, a large number of genes were differentially expressed between NP-lesion and control mares,
which is similar to studies on equine ascending placentitis [24–26] and human intra-amniotic infections [27].
Our results revealed that NP is dominated by Toll-like
receptor signaling, inflammasome activation, inflammatory signaling and apoptosis. Although, the current study
focused on the characterization of NP transcriptome
associated with Amycolatopsis spp, which is the most
common bacteria associated with this disease, further
studies are still warranted to assess the transcriptome of
NP associated with other bacteria (e.g., Crossiella equi,
Streptomyces atriruber and Streptomyces silaceus).
Although, the NPN samples didn’t show significant
difference in macroscopic and microscopic appearance
(i.e., inflammation score) compared to CRL samples, we
identified 89 DEGs in NPN vs. CRL set. This transcriptomic difference could be attributed to exocrine molecules released from the lesion (NPL) and consequently
affect the transcriptome of unaffected tissue (NPN). This
notion is supported by two recent retrospective studies
which have described the serum profile of mares with
focal mucoid placentitis (n = 6; two placentas were PCR
positive for the Amycolatopsis ssp, while the other four
had no bacteria detected) and found alterations in endocrine, cytokine, and feto-secretory markers in the weekly
assessed samples [28, 29]. In brief, these showed an
increase in IL-2, IL-5, IL-6, IL-10 and TNF in the maternal serum. Interestingly, the present study revealed that
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IL-6 is a potential upstream regulator for the DEGs identified in NPL vs. NPN dataset, which again supports our
notion. Additionally, the relatively small number of DEGs
in the NPN vs. CRL set was reflected in the close clustering of NPN and CRL samples (low inflammation score)
far from NPL samples (high inflammation score) in the
PCA and the heatmap. Noteworthy, the present study
identified 2189 DEGs (represent 69.5% of DEGs) in common between NPL vs. CRL and NPL vs. NPN sets. These
DEGs are the main focus of this discussion section unless
otherwise stated.
The central role of inflammatory mediators during placental infections is well established in women, mice and
mares [12, 30–32]. Likewise, the current study demonstrated that equine NP is principally dominated by inflammatory and immune responses, as revealed by functional
genomics analysis of DEGs. In brief, the NP transcriptome revealed the upregulation of a set of genes encoding the key regulators of the inflammatory cascade. These
include pattern recognition receptors (PRRs) such as
Toll-like receptors (TLRs) and Nod-like receptors (NLRs).
Of note TLRs are the primary and earliest recognition
mechanism for pathogen associated molecular patterns
(PAMPs) unique to the microorganisms with subsequent
activation of the inflammatory cascade [33, 34]. In the
present study, several TLRs (TLR1, TLR2, TLR3, TLR5,
TLR7 and TLR8) were significantly upregulated in NP. It
is noteworthy that TLR1/TLR2 heterodimers are responsible for recognition of gram-positive bacteria, consistent
with the Amycolatopsis spp. infection. Meanwhile, TLR5
is responsible for recognition of bacterial flagellin [33].
On the other hand, TLR3, TLR7 and TLR8 are responsible for recognition of viruses [33]. The upregulation of
the later TLRs might suggest presence of a viral component accompanying NP and/or indicate the upregulation of ligands that could activate these receptors [33].
This notion was somewhat supported by the overexpression of viral-related pathways (defense response to
virus and negative regulation of viral genome replication) in NPL as indicated by gene ontology analysis.
Upstream regulator analysis revealed the central role of
TLRs (2, 3, 5, 7, and 8) in NP. Furthermore, TLR2, TLR7,
and TLR8 showed up as hub genes in the turquoise module in the WGCNA database. Taking all together, these
findings address the principal role of TLRs as key regulators triggering the inflammatory cascade associated with
NP. Strategies to block TLRs hold potential for therapies
to block the inflammatory cascade and to forestall NP.
This notion is supported by studies showing that TLR
antagonists (TLRAs) were highly effective in preventing preterm birth induced by lipopolysaccharides (LPS),
heat-killed E. coli or platelet activating factor (PAF) in
primates and mice [35, 36].
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NLR signaling is a critical component in inflammasome
activation [37]. Inflammasomes are cytosolic multi-protein complexes that orchestrate the inflammatory cascade
[38]. Recently, we have elucidated that inflammasome
activation is implicated in equine ascending placentitis
[24]. Similarly, several inflammasome-related transcripts
(NLRC4, NLRC5, CASP1, IL1B, IL18, and GSDMD) were
significantly upregulated during NP in the current study.
Moreover, NLRC4, NLRC5, IL1B, IL18, and GSDMD
showed up as hub genes in the turquoise module in the
WGCNA database. Furthermore, IL1B and IL18 showed
up as upstream regulators in the present study. Taken all
together, these findings address the crucial role of NLRs
in triggering the inflammatory response associated with
NP. Therefore, targeting NLRs along with TLRs during NP might be promising for blocking the inflammatory cascade and to forestall placentitis-induced preterm
birth. This notion is supported by recent studies showing that the treatment of intra-amniotic infection using
NLR inflammasome inhibitors [39] resulted in inhibition
of prostaglandin synthesis with subsequent prevention of
infection-associated preterm birth in mice.
Among the mediators of inflammatory pathways,
chemokines are crucial for the activation and recruitment
of immune cells to the infection site [34, 40–43]. The
infiltrating immune cells are implicated in local inflammation, partly by releasing cytokine and matrix metalloproteinases (MMPs). These molecular events have been
reported in human chorioamnionitis and equine ascending placentitis [24, 34, 40–43]. Similarly, in the present
study, members of these gene groups of chemokines (e.g.,
CCL2, CCL8, CCL5, CXCL6, and S100A9), cytokines
(e.g., IL1α, IL1β, IL6, IL7, IL15 and IL18), and MMPs
(e.g., MMP1, MMP3, MMP8, and MMP12) were upregulated during NP. The upregulation of MMPs is implicated
in extracellular matrix (ECM) degradation and apoptosis
[24, 44–48]. Likewise, the apoptosis signaling pathway
and several apoptosis-related genes (CASP3, CASP4,
CASP7, CASP8, and CASP10) were overexpressed during
NP. The implication of MMPs and apoptosis in placental
separation have been described during term and preterm labor in women, mares and ruminants [24, 44–48].
Among the previously discussed molecules, IL1α, IL1β,
IL6, IL7, IL18, CCL5, S100A9, and CASP3 showed up as
upstream regulators for NP. Moreover, CCL (2, 3, 7, and
8), CXCL (6, 8, and 10), IL (1α, 1β, 6, 7, 18), CASP (3, 4, 7,
8, and 10), S100A9 and MMP8 showed up as hub genes in
NP as elucidated by WGCNA. Additionally, our results
revealed that the infiltrating immune cells significantly
affected the transcriptomic signature of nocardioform
placentitis. For instance, the inflammation score trait (i.e.,
degree of immune cell infiltration) showed the highest
adjacency to the turquoise module, which is the largest
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module (includes 54.71% of DEGs) in WGCNA dataset.
Therefore, the DEGs in this module might be triggered by
the infiltration of the placenta by immune cells. In support, pathway analysis of these DEGs revealed that they
are involved in pathways related to inflammatory cascade
and immune response. Taken together, these findings
highlight the central role of immune cells in orchestrating the localized placental inflammation and consequent
placental separation during NP.
Although the recruitment of immune cells to the infection site is a principal element of the innate immune
response against the invading pathogenic microorganism, host defense peptides (HDPs), also known as antimicrobial peptides (AMPs), represent another vital
element in this immune response [49–51]. HDPs represent potent and broad-spectrum antimicrobial properties. The expression of genes coding for HDPs is induced
by transcription factors due to the activation of TLRs
[49–51]. We recently reported that equine ascending placentitis is associated with upregulation of several genes coding for HDPs [24]. In agreement, NP was
associated with upregulation of several HDPs such as
lysozyme (LYZ), peptidase inhibitor 3 (PI3), secretory
phospholipase A2 (sPLA2; PLA2G2A), myeloid cathelicidin 3 (ECATH3), granulysin (GNLY), secretory leukocyte peptidase inhibitor (SLPI), acid phosphatase 5,
tartrate resistant (ACP5), and psoriasis (S100A7). In line
with our findings, the upregulation of several HDPs has
been reported in women with intra-amniotic infection
[52, 53] and mares with ascending placentitis [24]. Additionally, several reports have described the impressive
in vivo activities of HDPs [54, 55]. As a result, there has
been growing interest in HDPs as new treatment strategies for bacterial infections [54, 55]. So far, the efficacy
of HDPs as a potential treatment for equine NP has not
been tested.
In addition to the activation of the innate immune
response, NP also appears to lead to an upregulation of
the adaptive immune system, including T cell lymphocyte development and proliferation. T cell lymphocytes
are believed to be crucial for pregnancy maintenance
and proper embryo development, in addition to antigenspecific defense against pathogen [56, 57]. While Th1 and
Th2 cell types are essential for defense against intracellular and extracellular pathogens respectively, it is the balance between Th17 and Treg response which allows the
body to carry the pregnancy to term [24]. A disruption
of this balance has been indicated in various pregnancyrelated complications, including amniotic and placental
infection [58–60] and recurrent unexplained abortion
[61–64]. In the present study, NP was associated with an
increase in factors relating to the Th1 response (STAT1,
STAT4, TBX21, IL15, IL18). An upregulation of various
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Figure 10 Schematic illustration elucidating the expression pattern of T. cells related transcripts during NPL in comparison to CRL. The
FPKM of the selected genes were extracted from the transcriptome dataset and analyzed using student T-test. The arrow directions indicate if the
transcript is upregulated or downregulated in NPL in comparison to CRL. Key; CRL; normal postpartum (control), NPL; nocardioform placentitis
lesion, TBX21; T-Box Transcription Factor 21, IL; Interleukin, STAT; signal transducer and activator of transcription.

Th17-related transcripts was associated with NP (BATF,
IL17RC, IL21R, S100A9), but this was alongside a similar increase in Treg-related transcripts (CXCR4, SELL,
IL2RA, IL10RA). An increasing Th17 response along with
a dysregulated Treg response has been noted in various
types of pregnancy-related complications [57, 59, 63, 65,
66], and yet both apparently increased in NP. This dual
increase may explain the response to the pathogen and
the chronic nature of this disease, as all affected fetuses
resulted in live birth. The expression pattern of T-cells
related transcripts in NPL vs. CRL is summarized in
Figure 10.
In the current study, placental inflammation
was associated with aberrant expression of several

placenta-regulatory genes. For example, placenta-specific
8 (PLAC8), and galectin 1 (LGALS1) were significantly
upregulated during NP, while placenta-specific ATPBinding Cassette Transporter (ABCG2), chorion-specific
transcription factor GCMa (GCM1), endothelial PAS
domain protein 1 (EPAS1), and nuclear receptor subfamily 3 group C member 1 (NR3C1) were significantly
downregulated during the disease. Similarly, we recently
reported that equine ascending placentitis is accompanied by abnormal expression of PLAC8, LGALS1,
ABCG2, GCM1, and NR3C1 [24, 67]. It is likely that the
altered expression of these placenta-regulatory genes will
adversely affect the placental functions during placentitis.
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Within the NP transcriptome signature, we identified
aberrant expression of genes in insulin-like growth factor (IGF) signaling: IGFBP2, IGFBP6, IGFR1, and IGFR2.
The upregulation of the IGFBP2 and IGFBP6 could have
multiple paracrine and autocrine consequences throughout the context of NP. Secreted IGFBP2 and IGFBP6
have a high affinity for IGF1 and IGF2, respectively,
reducing their bioavailability to activate IGF signaling
[68]. Similarly, we have recently reported that equine
ascending placentitis is associated with upregulation of
IGFBP2, IGFBP4, and IGFBP7, and downregulation of
IGFR1 [24]. It is noteworthy that placental IGF signaling is implicated in fetal growth [69, 70]. Therefore, the
upregulation of IGFBP2 and IGFBP6 and downregulation of IGFR1 and IGFR2 during NP may suggest a
reduction in IGF signaling, consistent with the lower
birthweight we reported in the current study. Additionally, the present study revealed altered expression of several solute carrier (SLCs) genes. Of note, SLC is a family
of membrane-bound proteins (more than 300 proteins)
that facilitate the transport of a wide range of substrates
across biological membranes, including the placenta [71].
Our results revealed downregulation of approximately 31
SLCs, including glucose transporters (SLC2A1, SLC2A10,
and SLC2A12), amino acids transporters (SLC7A1, and
SLC38A4), fatty acids transporters (FABP1, FABP3,
VLDLR SLC25A17, SLC27A1 and SLC25A17), vitamin
transporters (SLC19A3), and adenosine triphosphate
(ATP) transporter (SLC25A17), among others. The downregulation of the above-mentioned SLCs could result in
a decline in transportation of maternal nutrients to the
growing fetus. Again, these findings are consistent with
lower birthweight of foals in the current study. Moreover,
our results showed that NP was associated with dysregulation of angiogenesis, as reflected by the downregulation of angiogenesis-related genes (e.g., VEGFA, KDR,
ANGPT2 and FLT1). Angiogenesis dysregulation could
result in a decline in placental blood perfusion (ischemia)
and, consequently, hypoxia in placental tissues [72]. This
notion is supported by the upregulation of hypoxiarelated genes (HIF1A and EGLN3) in NPL. Therefore, the
use of medicaments that improve placental angiogenesis
and/or blood flow might be beneficial for NP treatment.
Overall, the previously discussed molecular mechanisms
underlying dysregulation of placental angiogenesis and
nutrient transportation, as well as placental hypoxia,
could explain placental insufficiency during NP.
Identifying the gene expression signature that is intrinsic for equine NP is potential for future in vitro and/or
in vivo studies. Additionally, if the proteins coded by
these genes are released from the placentitis lesion into
the maternal circulation and can be measured, these proteins might serve as reliable and sensitive biomarkers
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for equine NP. The current study revealed that 105
genes were exclusively expressed in NPL in comparison
to control (i.e., zero FPKM in CRL set). Some of these
transcripts encode proteins that have been proposed
as potential biomarkers for intra-amniotic infection or
inflammation in women with preterm labor [73, 74],
such as ENSECAG00000008686 (psoriasis; S100A7) and
ENSECAG00000010615 (calgranulin B; S100A9). On
the other hand, the top ten exclusively expressed genes
(based on abundance in NPL) were novel genes. Gene
homology analysis of these ten genes revealed that six
of them are homologous to human and mouse immunoglobulin kappa constant (IGKCs; ENSECAG00000001923
and
ENSECAG00000001923),
immunoglobulin
lambda constant (IGLCs; ENSECAG00000015109,
ENSECAG00000031522, and ENSECAG00000039599),
and
immunoglobulin
heavy
variable
(IGHVs;
ENSECAG00000028730), while the remaining four genes
did not show any homology to human and mouse genes.
Further studies are required to assess the utility of the
immunoglobulins as potential biomarkers for equine
NP. Overall, these NP exclusively expressed transcripts
represent an intrinsic signature for equine NP, and further studies are required to elucidate their role in the NP
pathway. Further studies to assess their associate proteins
as potential biomarkers for equine NP are warranted.
In the present study, the RNA integrity of RNA isolated from CA collected within three hours after foaling
was consistently high (RIN > 9) which suggests that this
sampling strategy of collecting CA on farm and preservation in RNAlater® could be effective for further studies on term equine placenta. This observation is similar
to studies of human term placenta where preservation of
decidua in RNA later yielded high RNA integrity [75].
There are some potential limitations to our study. These
limitations relate to obtaining samples at the beginning
of the disease because nocardioform placentitis is always
diagnosed in the disease’s late stages, and it is difficult to
obtain prepartum samples from clinical cases. Moreover,
there is no valid experimental model for the disease that
would us to collect samples at the early stages of the disease. Similar to these limitations, human studies that are
concerned with clinical chorioamnionitis or spontaneous preterm birth use a similar sampling time point (i.e.,
no samples are obtained at the beginning of the disease),
and results from these studies are still acknowledged in
human reproductive science [34, 40]. Furthermore, it is
believed that the bacterial infection during NP starts at
the center of the lesion and then progresses/expands outward. Therefore, we believe that the current sampling site
(i.e., the margin of the lesion [NPL]) would reflect many
of the molecular mechanisms associated with the early
interaction between the bacteria and the chorioallantois.
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Figure 11 Schematic illustration explaining the possible mechanisms associated with equine nocardioform placentitis in light of the
current study. The arrow directions indicate if the gene is upregulated or downregulated in the current study.

In conclusion, on-farm collection of the CA from mares
within three hours after foaling yielded RNA suitable for analysis by high-throughput sequencing. This
is the first study to describe the equine CA transcriptome during NP. Our results revealed the central role
of TLRs and NLRs in triggering the inflammatory signaling and inflammasome activation, respectively, during NP, and this resulted in placental inflammation and
immune cell chemotaxis. The increased leukocytic infiltration was associated with the upregulation of MMPs
and apoptosis-related genes, believed to be implicated in
placental separation during NP. NP was associated with

aberrant expression of several placenta-regulatory genes
and dysregulation of placental angiogenesis, and nutrient transportation, as well as placental hypoxia, which
could explain placental insufficiency during NP. The significant findings of the current dataset are summarized
in Figure 11. Beyond the NP-associated events described
in the current study, this study provides a comprehensive database of the key upstream regulators, TFs, hub
genes, receptor-ligand interactions, gene co-expression
networks associated with equine nocardioform placentitis. Strategies to block the key upstream regulators (e.g.,
TLRs and NLRs) and associated pathways hold potential

El‑Sheikh Ali et al. Vet Res

(2021) 52:103

for therapies to overcome NP. Together, the currently
revealed placentitis transcriptome signature improves
our understanding of the disease. Also, it provides an allessential basis for the construction of new hypotheses to
be tested in the future. Finally, much more valuable information remains to be mined from the current transcriptome dataset.
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(cluster) as generated by WGCNA. B) Intramodular hub genes in the
turquoise module.
Additional file 7. List of predicted ligand and receptor pairs and their
expression patterns in equine chorioallantois (CA) during nocardi‑
oform placentitis dataset.
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